Clinical Trial Update: Study of Oral Uremic Toxin Absorbent and Probiotics to Retard the Progression of Chronic Kidney Disease [NA]

View source ↗

Summary

A clinical trial from National Taiwan University Hospital is evaluating an oral uremic toxin absorbent and probiotics to slow progression of chronic kidney dise…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Oral uremic toxin absorbent
• Probiotics

Snippet

Sponsor: National Taiwan University Hospital | Conditions: CKD | NA | Status: RECRUITING